Guselkumab Provides Relief For Patients Who Suffer With Psoriasis Overview A 52-week postmarketing surveillance study was launched to assess the safety and effectiveness of guselkumab, a human monoclonal antibody targeting the interleukin-23 subunit p19, in Japanese patients diagnosed with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis in real-world clinical
Tag: Psoriasis
Brilliant Use Of Probiotic Medication To Treat Psoriasis
Brilliant Use Of Probiotic Medication To Treat Psoriasis Psoriasis, a chronic inflammatory skin disease, severely affects physical and mental health, often causing severe itching. Its prevalence is increasing, especially in developed countries, and is linked to genetics, immune disorders, infections, and environmental factors. Traditional treatments include topical corticosteroids and biologics, but
Piclidenoson In The Treatment Of Plaque Psoriasis
Piclidenoson In The Treatment Of Plaque Psoriasis Overview The study focused on evaluating the effectiveness and safety of piclidenoson (CF101), an orally bioavailable agonist for the A3 adenosine receptor (A3AR), in treating moderate-to-severe plaque psoriasis. The A3AR is known to be overexpressed in the skin and peripheral blood mononuclear cells of individuals
Secukinumab Therapy In Psoriasis
Secukinumab Therapy In Psoriasis Overview Psoriasis is a chronic skin condition characterized by immune-mediated inflammation, significantly affecting patients' quality of life. Secukinumab, an interleukin 17A inhibitor, has been employed as a systemic treatment for psoriasis. However, its long-term retention rates in a real-world setting in Japan have not been comprehensively studied. In
Psoriasis Risk In Children With High BMI
Psoriasis Risk In Children With High BMI Overview This study aimed to investigate the potential association between childhood body mass index (BMI) and the risk of psoriasis. Using publicly available summary statistics from genome-wide association studies (GWAS) that focused on childhood BMI in individuals of European descent (n=39,620), the researchers conducted a
